Cellectar Biosciences, Inc. (CLRB)
NCM – Real vaqt narxi. Valyuta: USD
2.70
-0.20 (-6.90%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
2.70
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 7:12 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
2.70
-0.20 (-6.90%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
2.70
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 7:12 PM EDT
Cellectar Biosciences, Inc., klinik biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonni davolash uchun dori vositalarini kashf qilish, ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniyaning yetakchi fosfolipid dori-konjugat (PDC) nomzodi CLR 131 (iopofosina I-131) bo'lib, u B-hujayrali maligniteti bo'lgan bemorlar uchun 2-bosqich klinik tadqiqotda; qaytalangan yoki refrakter (r/r) Waldenstrom makroglobulinemiyasi kohortasi, r/r ko'p miyeloma (MM) kohortasi va r/r non-Hodgkin limfoma kohortasi bo'lgan bemorlar uchun 2a-bosqich klinik tadqiqotda; tanlangan qattiq o'smalar, limfomalar va malign miya o'smalari bo'lgan r/r pediatrik bemorlar uchun 1-bosqich klinik tadqiqotda; va bosh va bo'yin saratoni bo'lgan r/r bemorlar uchun 1-bosqich klinik tadqiqotda. Kompaniya shuningdek, yod-125 auger-emitentli radiokonjugat dasturi bo'lgan CLR125; va aktinium-225 asosidagi dastur bo'lgan CLR 225ni ishlab chiqadi. Kompaniya Orano Med bilan fosfolipid efir seriyasiga biriktirilgan alfa-emitentli qo'rg'oshin-212ni ishlab chiqish bo'yicha hamkorlik qiladi; va LegoChem Bio. Cellectar Biosciences, Inc. 2002 yilda tashkil etilgan va Florham Park, Nyu-Jersi shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Chad J. Kolean CPA | VP, CFO & Secretary |
| Mr. James V. Caruso | President, CEO & Director |
| Mr. Jarrod Longcor | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-04 | 8-K | tm267955d1_8k.htm |
| 2025-11-13 | 10-Q | clrb-20250930x10q.htm |
| 2025-10-20 | S-1 | tm2529020d1_s1.htm |
| 2025-10-10 | 8-K | tm2528473d1_8k.htm |
| 2025-10-06 | 8-K | tm2528016d1_8k.htm |
| 2025-08-14 | 8-K | tm2523504d1_8k.htm |
| 2025-06-30 | CORRESP | filename1.htm |
| 2025-06-26 | 8-K | tm2519054d1_8k.htm |
| 2025-06-25 | 8-K | tm2519011d1_8k.htm |
| 2025-06-18 | 8-K | tm2518341d1_8k.htm |